R
Robert W. Georgantas
Researcher at Johns Hopkins University
Publications - 17
Citations - 1063
Robert W. Georgantas is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Haematopoiesis & CD34. The author has an hindex of 9, co-authored 15 publications receiving 1014 citations. Previous affiliations of Robert W. Georgantas include Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.
Robert W. Georgantas,Richard Hildreth,Sebastien Morisot,Jonathan K. Alder,Chang Gong Liu,Shelly Heimfeld,George A. Calin,Carlo M. Croce,Curt I. Civin +8 more
TL;DR: This work found 33 miRNAs expressed in CD34+ hematopoietic stem-progenitor cells (HSPCs) from normal human bone marrow and mobilized human peripheral blood stem cell harvests, and formulated a model for miRNA control of stages of heMatopoiesis in which many of the genes specifying hematopolietic differentiation are expressed by HSPCs, but are held in check by miRNAAs until differentiation occurs.
Journal ArticleDOI
Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo
Jonathan K. Alder,Robert W. Georgantas,Richard Hildreth,Ian M. Kaplan,Sebastien Morisot,Xiaobing Yu,Michael A. McDevitt,Curt I. Civin +7 more
TL;DR: In vivo loss-of-function studies demonstrate that KLF4, previously shown to mediate proinflammatory signaling in human macrophages in vitro, is essential for differentiation of mouse inflammatory monocytes, and is involved in the differentiation of resident monocytes.
Journal ArticleDOI
Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
Robert W. Georgantas,Vivek Tanadve,Matthew T Malehorn,Shelly Heimfeld,Chen Chen,Laura Carr,Francisco Martinez-Murillo,Greg Riggins,Jeanne Kowalski,Curt I. Civin +9 more
TL;DR: Analysis of gene expression in CD34+/CD38−/Lin− cell populations isolated from normal human adult donor bone marrow, neonatal placental/umbilical cord blood, and mobilized adult donor peripheral blood stem-progenitor cells suggested that current microarrays do not detect as many as 30% of the transcripts expressed in HSCs, including a number of previously unknown transcripts.
Patent
Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof
TL;DR: In this paper, methods and compositions for modulating the differentiation of incompletely differentiated cells, such as stem-progenitor cells, e.g., hematopoietic stem- progenitor cells.
Patent
Therapeutic and diagnostic applications of genes differentially expressed in lympho-hematopoietic stem cells
TL;DR: The discovery of novel group of genes and/or their encoded gene products that are differentially represented in two substantially enriched CD34+/CD38−/Lin− and CD 34+/[CD38/Lin]++ hematopoietic cell populations isolated from normal human bone marrow, cord blood, and peripheral blood stem cell preparations is described in this article.